Think about product development cycles for technology and what we know, for example about smartphones. Apple and Samsung have publicly stated that when a new phone drops, the next model of that phone is already designed, has been pretty much prototyped and specced for production - at least from a core hardware perspective.
So EAP customers have had in their hands the physical chips for about 7 months now. That means they will have been able to implement bench models of their device and integrate AKD1000 into the bench version of the device. Bench version - meaning - the hardware is all there for the phone, but it would look like it was in pieces connected by wires - it certainly wouldn't fit in your pocket and the only thing that would make it recognisable as a phone would be the touch screen. The last thing to be designed is the physical case and how the thing looks, which takes very little time to turn around.
Apple (for example) release new phones in September. So if they were playing with Akida - their current bench phone would be at prototype stage by then, meaning the earliest I could see Apple releasing an iphone with Akida inside being September 2023.
Outside of Apple and Samsung, most smartphone manufacturers rely on Qualcomm SOCs for their phones - so Qualcomm has to have an SOC for these manufacturers to play around with before it gets prototyped. This all takes time. So yeah, 12-18 months isn't unrealistic.
- Forums
- ASX - By Stock
- Interview with Peter van der Made
Think about product development cycles for technology and what...
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
27.5¢ |
Change
0.030(12.2%) |
Mkt cap ! $505.7M |
Open | High | Low | Value | Volume |
25.0¢ | 28.0¢ | 24.5¢ | $4.425M | 16.95M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 218240 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 789196 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 567286 | 0.270 |
25 | 1488174 | 0.265 |
21 | 525295 | 0.260 |
20 | 456053 | 0.255 |
35 | 795880 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 150819 | 13 |
0.280 | 679663 | 29 |
0.285 | 652482 | 13 |
0.290 | 515572 | 14 |
0.295 | 698050 | 19 |
Last trade - 14.40pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
27.5¢ |
  |
Change
0.030 ( 12.1 %) |
|||
Open | High | Low | Volume | ||
25.0¢ | 28.0¢ | 24.5¢ | 13521486 | ||
Last updated 15.01pm 06/05/2024 ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online